Merck on Track to Seek FDA Approval of Diet Drug Taranabant in 2008
Acomplia, Struggling With Slow European Sales, Gets More Bad News in UK

Taranabant Yields Encouraging Results With 'Generally Mild' Side-Effects
First Official Report on Diet Drug Taranabant Due October 24th
Newspaper Ads Disguised as Stories Tout Apatrim as New 'Miracle' Diet Pill

Diet Drug Rimonabant Found to Reduce Dangerous Abdominal Fat in Study
Danish Diet Drug Produces Amazing Weight Loss in 24-Week Clinical Trial
Sanofi: No Plans to Try to Sell Diet Drug Acomplia in U.S. for Several Years
Diet Drug Taranabant Prospects Look Encouraging as Study Nears End

Zimulti (Rimonabant) Not Likely to Be on Sale in U.S. Pharmacies for Years

Merck Rehires Top Marketeer to Promote Acomplia Competitor Taranabant
Diet Drug Empatic Produces Significant Weight Loss in Phase IIb Trial
Rimonabant (Acomplia) Benefits 'Outweigh Risks' -- European Regulators
With Acomplia on Hold in U.S., Is Contrave the Next Great Diet Drug Hope?

Sanofi Pulls U.S. Application to Sell Diet Pill Rimonabant (Acomplia)
Sanofi Appeal on Rimonabant Reimbursement Rejected by German Court
Indian Pharmas: No Plans to Withdraw Rimonabant From the Market
Anti - alli Attack Commercial Turned Down by Major Television Networks
European Regulators to Review Safety Data for Diet Drug Acomplia
FDA Panel Unanimously Recommends Against Approval of Rimonabant
400,000 Diet Pill alli Starter Kits Being Shipped to U.S. Stores for Launch
FDA Ties Diet Drug Rimonabant Delay to 'Psychiatric Adverse Effects'
Big Week Ahead as alli Goes on Sale and FDA Weights Fate of Rimonabant
It's Official. Diet Pill alli Will Go on Sale Across America on June 15th
Diet Drug Acomplia (Rimonabant) Launched in United Arab Emirates
Diet Pill Acomplia (Rimonabant) Widely Sold in Mexican Border Pharmacies

British Experts: Orlistat (Xenical / alli) Better Diet Choice Than Acomplia
How Indian Pharmas Beat Sanofi to the Market With Diet Drug Rimonabant
Diet Pill alli (Low-Dose Xenical) to Go on Sale in U.S. on June 15th
Counterfeit Acomplia Ring Cracked by Police Raids in Europe
Trodusquemine in Phase I Clinical Trial for Obesity and Diabetes
Diet Pill Acomplia Sales in Europe Seen Disappointing

Diet Pill alli May Also Be Available Over-the-Counter in Europe by Late 2008
Merck Competitor for Diet Drug Acomplia (Rimonabant) Named Taranabant

Diet Pill Acomplia Safety Concerns to Be Aired by FDA Panel in June
Diet Pill alli Begins Recruiting 400 Would-Be Dieters for Prelaunch Test
Diet Drug Rimonabant Faces Severe Reimbursement Limitations in France
Diet Pill Rimonabant (Acomplia / Zimulti) Seen Top Diet Drug in 2010
Diet Drug Acomplia (Rimonabant) on Sale in Mexican Border Pharmacies

Diet Drug AOD9604, Once Subject of High Hopes, Terminated as Failure
Diet Pill alli (Low-Dose Xenical) May Ultimately Be Marketed Worldwide
FDA Action on Diet Drug Rimonabant Is Again Delayed as New Data Is Filed
Newsletter alli Report Launches Discussion Forum for alli and Xenical
Tale of 2 Orlistats: Will Diet Pill alli Succeed Where Xenical Failed?
Diet Pill Alli (Half-Strength Xenical) Approved by FDA for O-T-C Sale in U.S.

Diet Drug Based on Natural Hormone Secreted in Gut Gets Funding in UK
Diet Pill Rimonabant Rejected for Insurance Reimbursement in Germany
Prescription Diet Drug for Dogs (Not Humans) Approved by FDA
More Studies Needed of Long-Term Benefits of Diet Pills Versus Risks
U.S. Fines Diet Pill Marketers $25 Million for False Advertising Claims
Is FDA Having Second Thoughts on O-T-C Sale of Diet Pill Alli (Orlistat)?